Molluscum or a Mimic? Add Penicillium marneffei!

American Journal of Medicine

Volumn 120, Issue 11, 2007, Pages

  Antinori, Spinello ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; FLUCONAZOLE;

BACTERIAL INFECTION; CRYPTOCOCCOSIS; DOSE RESPONSE; DRUG DOSE INCREASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PENICILLIOSIS; PENICILLIUM MARNEFFEI; PRIORITY JOURNAL; SKIN DEFECT;

ANTIFUNGAL AGENTS; ANTIGENS, FUNGAL; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CRYPTOCOCCOSIS; FLUCONAZOLE; HIV INFECTIONS; HUMANS;

EID: 35448999283     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2006.12.006     Document Type: Letter

References (10)

1. de Souza J.A. Molluscum or a mimic?. Am J Med 119 (2006) 927-929
2. Martinez E., Garcia-Viejo M.A., Marcos M.A., et al. Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy. AIDS 14 (2000) 2615-2617
3. Rollot F., Bossi P., Tubiana R., et al. Discontinuation of secondary prophylaxis against cryptococcosis in patients with AIDS receiving highly active antiretroviral therapy. AIDS 15 (2001) 1448-1449
4. Nwkolo N.C., Fischer M., Gazzard B.G., and Nelson M.R. Cessation of secondary prophylaxis in patients with cryptococcosis. AIDS 15 (2001) 1438-1439
5. Aberg J.A., Price R.W., Heeren D.M., and Bredt B. A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy. J Infect Dis 185 (2002) 1179-1182
6. Sheng W.H., Hung C.C., Chen M.Y., Hsieh S.M., and Chang S.C. Successful discontinuation of fluconazole as secondary prophylaxis for cryptococcosis in AIDS patients responding to highly active antiretroviral therapy. Int J STD AIDS 13 (2002) 702-705
7. Kirk O., Reiss P., Uberti Foppa C., et al. Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy. Ann Intern Med 137 (2002) 239-250
8. Vibhagool A., Sungkanuparph S., Mootsikapan P., et al. Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective multicenter, randomized study. Clin Infect Dis 36 (2003) 1329-1331
9. Mussini C., Pezzotti P., Mirò J.M., et al. Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study. Clin Infect Dis 38 (2004) 565-571
10. Sun H.Y., Chen M.Y., Hsiao C.F., Hsieh S.M., Hung C.C., and Chang S.C. Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated with highly active antiretroviral therapy. Clin Microbiol Infect 12 (2006) 381-388